
Arbutus Sues Moderna Over Patent Infringement
As part of its lawsuit against Moderna Inc, Arbutus Biopharma Corp said on Monday that it had sought damages for infringement of its COVID-19 patent. Patents belonging to Arbutus Biopharma that were licensed to Genevant Sciences were rejected by an appeals court last December, prompting Moderna’s lawsuit against Arbutus Biopharma. Accordingly, the court upheld the










